Cargando…

Targeting miR‐126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells

BACKGROUND: Myelodysplastic syndrome (MDS) arises from a rare population of aberrant hematopoietic stem and progenitor cells (HSPCs). These cells are relatively quiescent and therefore treatment resistant. Understanding mechanisms underlying their maintenance is critical for effective MDS treatment....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huafeng, Sun, Jie, Zhang, Bin, Zhao, Dandan, Tong, Hongyan, Wu, Herman, Li, Xia, Luo, Yingwan, Dong, Dan, Yao, Yiyi, McDonald, Tinisha, Stein, Anthony S., Al Malki, Monzr M., Pichiorri, Flavia, Carlesso, Nadia, Kuo, Ya‐Huei, Marcucci, Guido, Li, Ling, Jin, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516361/ https://www.ncbi.nlm.nih.gov/pubmed/34709739 http://dx.doi.org/10.1002/ctm2.610

Ejemplares similares

Bone Marrow Niche Trafficking of miR-126 Controls Self-Renewal of Leukemia Stem Cells in Chronic Myelogenous Leukemia
por: Zhang, Bin, et al.
Publicado: (2018)

Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML
por: Zhang, Bin, et al.
Publicado: (2021)

Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: A case report and literature review
por: Sun, Chuanyin, et al.
Publicado: (2018)

Targeting miR-126 in Ph+ acute lymphoblastic leukemia
por: Qiao, Junjing, et al.
Publicado: (2023)

Role of BCR-ABL-Y177 mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors
por: Chu, Su, et al.
Publicado: (2010)

Cytoplasmic DROSHA and Non-canonical Mechanisms of MiR-155 Biogenesis in FLT3-ITD Acute Myeloid Leukemia
por: Nguyen, Le Xuan Truong, et al.
Publicado: (2021)

Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance
por: Zhang, Lianjun, et al.
Publicado: (2021)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
por: Yan, Xuefen, et al.
Publicado: (2021)

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes
por: Jiang, Lingxu, et al.
Publicado: (2019)

P699: MAGROLIMAB ALTERS THE TUMOR MICROENVIRONMENT TO IMPROVE BONE MARROW FUNCTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)
por: Johnson, Lisa, et al.
Publicado: (2023)

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
por: Zhou, Xinping, et al.
Publicado: (2023)

At S126
por: CERN PhotoLab
Publicado: (1974)

At S126
por: CERN PhotoLab
Publicado: (1974)

The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes
por: Lin, Peipei, et al.
Publicado: (2019)

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes
por: Ostendorf, Benjamin N., et al.
Publicado: (2018)

Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone
por: Ye, Li, et al.
Publicado: (2017)

MicroRNA-126 and VEGF enhance the function of endothelial progenitor cells in acute myocardial infarction
por: Zhang, Ying, et al.
Publicado: (2022)

Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Ali, Haris, et al.
Publicado: (2021)

Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes
por: Xing, Tong, et al.
Publicado: (2022)

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells
por: Luo, Bingqing, et al.
Publicado: (2022)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
por: Dussiau, Charles, et al.
Publicado: (2023)

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder
por: Braun, Adam, et al.
Publicado: (2023)

A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes
por: Tong, Hongyan, et al.
Publicado: (2013)

Nature or Nurture? Role of the Bone Marrow Microenvironment in the Genesis and Maintenance of Myelodysplastic Syndromes
por: Mian, Syed A., et al.
Publicado: (2021)

The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study
por: Ngo, Dat, et al.
Publicado: (2023)

Wnt Signaling Is Required for the Maintenance of Human Limbal Stem/Progenitor Cells In Vitro
por: González, Sheyla, et al.
Publicado: (2019)

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex
por: Wang, Lu, et al.
Publicado: (2022)

Downregulation of hTERT: An Important As(2)O(3) Induced Mechanism of Apoptosis in Myelodysplastic Syndrome
por: Xu, Weilai, et al.
Publicado: (2014)

The Role of Circulating MicroRNA-126 (miR-126): A Novel Biomarker for Screening Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus
por: Liu, Yang, et al.
Publicado: (2014)

Securing the graft during pandemic: are we ready for cryopreservation for all?
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2020)

miR-126 and miR-126*: New Players in Cancer
por: Meister, Jeannette, et al.
Publicado: (2010)

Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration
por: Jain, Tania, et al.
Publicado: (2023)

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation
por: Behbehani, Gregory K., et al.
Publicado: (2020)

Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice
por: Jin, Xin, et al.
Publicado: (2018)

A magnet for S126
Publicado: (1974)

Wire chambers for S126
Publicado: (1974)

126 Stones in the Bladder
por: Daruvala, Bamanji Pestanji
Publicado: (1912)

Discovering Transcription and Splicing Networks in Myelodysplastic Syndromes
por: Wang, Hongyan, et al.
Publicado: (2013)

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
por: Jain, Tania, et al.
Publicado: (2023)

A new method for maturity-dependent fractionation of neutrophil progenitors applicable for the study of myelodysplastic syndromes
por: Hu, Huiyuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jtcso3slnv4flcs3bjetu1a7fi